Many early workflows lack scalability, relying on temperature-sensitive steps, outdated purification tools or unnecessary customization. These design flaws often derail timelines and inflate costs ...

Mark Perreault is Senior Director of Research & Development at Repligen Corp., a bioprocessing-focused life sciences company bringing expertise and innovation to customers since 1981. Mark earned his ...

Continuous manufacturing makes monoclonal antibody production faster, cheaper, and greener, say researchers, who predict that industry adoption of the approach will accelerate in response to ...

To develop monoclonal antibody biomanufacturing innovations and produce an anti-filovirus Medical Countermeasure.

Discover the latest insights in monoclonal antibody production with this exclusive eBook: "Monoclonal Antibody Manufacturing Trends." Published by Cell Culture Dish, this eBook delves into the current ...

Next-generation monoclonal antibodies (mAbs), including bispecifics and multimerized formats, present increasingly complex purification challenges. Unique structural features and elevated impurity ...

Real-time and in-line accurate measuring of protein (monoclonal antibody, or mAb) concentration has been shown across a wide dynamic range (0–135 g/L) through the ...

DURHAM, N.C.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), announces a manufacturing contract ...

"Abzena and Mabqi partner for drug development solution" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.